In 2020, the Jefferies London Healthcare Conference hosted over 550 participating companies, 3,000 attendees, and 6,500 business-to-business and investor meetings. The 2021 conference will again feature leading public and private companies from the pharmaceuticals, biotechnology, medical technology, and healthcare services sectors from the Americas, Europe, Middle East, Africa, Asia, and Australia.
Jefferies London Healthcare Conference 2021 will be held both in-person in London and virtually, featuring live and on-demand presentations, fireside chats, panels and small group meetings to connect companies and investors.
Mogrify is pioneering a new class of in vivo reprogramming therapies and transforming the development of ex vivo cell therapies for immuno-oncology, ophthalmology and other disease areas. Using its proprietary suite of platform technologies to identify in silico the key transcription factors (with MOGRIFY®) and growth factors (with epiMOGRIFY™) to drive the speed, efficiency and maintenance of direct cellular reprogramming.